The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, Issue of Equity & Rule 2.9

21 Dec 2020 15:59

RNS Number : 4225J
Horizon Discovery Group plc
21 December 2020
 

Horizon Discovery Group plc

("Horizon" or the "Company")

 

Exercise of Options, Issue of Equity and Rule 2.9 announcement

 

Cambridge, UK - 21 December 2020: Horizon Discovery Group plc (LSE: HZD), a cell engineering company focused on commercialising the application of gene editing and gene modulation, announces that, following the Court sanctioning the Scheme in relation with the recommended cash offer by PerkinElmer UK earlier today, the Company has today allotted and issued a total of 5,850,657 new ordinary shares of £0.01 each in the Company ("Ordinary Shares") pursuant to the exercise of options. This comprises 4,000,443 options exercised today, 21 December 2020, by certain employees and former employees and 1,850,214 options exercised today by the following PDMRs:

 

Name

Number of options exercised

Respective option plan

Exercise Price per share

Ian Gilham

57,300

EMI Scheme

£0.6774

Ian Gilham

85,950

EMI Scheme

£0.8726

Jayesh Pankhania

17,167

LTIP

£1.7475

Jayesh Pankhania

111,588

LTIP

£1.7475

Jayesh Pankhania

45,064

LTIP

£0.01

Jayesh Pankhania

419,817

LTIP

£1.64

Jayesh Pankhania

57,712

LTIP

£0.01

Siddhartha Kadia

150,000

LTIP

£1.03

Terry Pizzie

60,185

LTIP

£1.62

Terry Pizzie

7,812

LTIP

£0.01

Terry Pizzie

15,031

LTIP

£1.57

Terry Pizzie

41,401

LTIP

£0.01

Terry Pizzie

70,730

LTIP

£0.01

Terry Pizzie

624,594

LTIP

£1.64

Terry Pizzie

85,863

LTIP

£0.01

 

As a result of the option exercises, the PDMRs have increased their shareholdings as detailed below:

 

 

Options exercised in aggregate

No. of ordinary shares in which the Directors (or their close relatives) had an interest before the option exercise

No. of ordinary shares held in the Company following the option exercises

Ian Gilham

143,250

145,592

288,842

Terry Pizzie

905,616

42,285

947,901

Jayesh Pankhania

651,348

90,768

742,116

Siddhartha Kadia

150,000

0

150,000

 

As a result of the exercise of options, application has been made for the 5,850,657 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 22 December 2020. The new Ordinary Shares will rank pari passu with the existing shares of the Company.

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Horizon confirms that, on 21 December 2020 (the date of this announcement), it has 164,214,591 ordinary shares of £0.01 each in issue. The International Securities Identification Number ("ISIN") for the Company's ordinary shares is GB00BK8FL363.

The above figure (164,214,591) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used in this announcement (the "Announcement"), unless otherwise defined, have the same meanings as set out in the Scheme Document.

 

Enquiries:

Horizon

Terry Pizzie, Chief Executive Officer Tel: +44 (0) 122365 5580 

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Evercore (Lead Financial Adviser to Horizon)

Simon Elliott Tel: +44 (0) 20 7653 6000

Edward Banks

Numis (Joint Financial Adviser, Broker and NOMAD to Horizon)

Freddie Barnfield Tel: +44 (0) 20 7260 1000

Stuart Ord

Duncan Monteith

Consilium Strategic Communications (Financial Media and UK Investor Relations Adviser to Horizon)

Mary-Jane Elliott Tel: +44 (0) 7720 088 468

Matthew Neal

Melissa Gardiner

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Ian Gilham

2.

Reason for notification

a)

Position / status

Non-executive Chairman

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

57,300

£0.6774

85,950

£0.8726

 

 

d)

Aggregated information

Aggregated volume

Price

 

143,250

£113,814.99

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Terry Pizzie

2.

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

60,185

£1.62

7,812

£0.01

15,031

£1.57

41,401

£0.01

70,730

£0.01

624,594

£1.64

85,863

£0.01

d)

Aggregated information

Aggregated volume

Price

 

905,616

£1,147,490.59

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Jayesh Pankhania

2.

Reason for notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

17,167

£1.7475

111,588

£1.7475

45,064

£0.01

419,817

£1.64

57,712

£0.01

d)

Aggregated information

Aggregated volume

Price

 

651,348

£914,527.00

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Siddhartha Kadia

2.

Reason for notification

a)

Position / status

Non-executive Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

150,000

£1.03

d)

Aggregated information

Aggregated volume

Price

 

150,000

£154,500.00

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZZKMNGGZM
Date   Source Headline
25th Mar 20157:00 amRNSHorizon Discovery awarded AMSCI grant
24th Mar 20157:00 amRNSNotice of Preliminary Results
23rd Mar 20157:00 amRNSHorizon Discovery and ArcherDX Sign OEM Agreement
18th Mar 201510:39 amRNSAdditional Listing
11th Mar 20157:00 amRNSHorizon Provides Genomic Standards To CRUK
18th Feb 20157:00 amRNSInnovate UK funding award
11th Feb 20154:27 pmRNSAdditional Listing
5th Feb 201512:21 pmRNSAdditional Listing
2nd Feb 20157:00 amRNSHorizon Discovery Selected as Core Facility
27th Jan 201512:00 pmRNSAdditional Listing
23rd Jan 20154:46 pmRNSHolding(s) in Company
19th Jan 20157:00 amRNSRevenues expected to be ahead of consensus by 7%
15th Jan 20157:00 amRNSHolding(s) in Company
8th Jan 20157:00 amRNSAcquisition of Haplogen Genomics GmbH
30th Dec 20147:00 amRNSHorizon Discovery Group Signs Agreement for $810K
22nd Dec 20144:49 pmRNSAdditional Listing
19th Dec 20146:23 pmRNSHolding(s) in Company
8th Dec 20147:00 amRNSLaunch of Gene-Engineered Bioproduction Cell Line
26th Nov 20143:09 pmRNSHolding(s) in Company
24th Nov 20147:00 amRNSHorizon Enter Agreement with Adarza BioSystems
19th Nov 201412:26 pmRNSHolding(s) in Company
17th Nov 20147:00 amRNS$750,000 contract win from top ten pharma
3rd Nov 20147:00 amRNSAppoints Dr David Smoller as an Executive Director
15th Oct 20147:00 amRNSHorizon CombinatoRx Wins Contract
6th Oct 20143:14 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Oct 20147:00 amRNSCo-Exclusive Commercial Agreement Signed
29th Sep 20147:00 amRNSAcquires Sage Labs Inc. for $48M (£29M)
25th Sep 201412:30 pmRNSAdditional Listing
25th Sep 20147:00 amRNS$1.2 million Master Services Agreement
23rd Sep 20147:00 amRNSInterim Results for Six Months Ended 30 June 2014
17th Sep 20144:34 pmRNSHolding(s) in Company
15th Sep 20145:29 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Sep 201410:17 amRNSAdditional Listing
3rd Sep 20147:00 amRNSNotice of Interim Results
5th Aug 20147:00 amRNSCRISPR Experts Join Scientific Advisory Board
28th Jul 20143:57 pmRNSAdditional Listing
25th Jul 20147:00 amRNSHZD sign Collaboration Agreement with Otsuka
23rd Jul 20147:00 amRNSTrading Update
3rd Jul 20147:00 amRNSLicenses AAV Gene Delivery Technology
19th Jun 201410:48 amRNSDirector/PDMR Shareholding
17th Jun 20143:35 pmRNSAdditional Listing
16th Jun 20147:00 amRNSTSB Grant for next generation cancer diagnostics
12th Jun 20147:00 amRNSLicenses CRISPR Technology from Broad Institute
11th Jun 201412:11 pmRNSDirector/PDMR Shareholding
9th Jun 20147:00 amRNSAppointment of two Non-Executive Directors
2nd Jun 20147:00 amRNSCompletion of Acquisition of CombinatoRx
15th May 20147:00 amRNSAcquisition
8th May 20147:00 amRNSHolding in Company
8th May 20147:00 amRNSLicenses Gene Editing Technology from ERS Genomics
6th May 20145:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.